Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to determine the pharmacokinetic and safety of BMS-986435 in participants with normal hepatic function and participants with different degrees of hepatic impairment
Official title: A Phase 1, Multi-center, Open-label, Single-dose Study to Assess the Pharmacokinetics and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Mild and Moderate Hepatic Impairment
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2025-12-15
Completion Date
2026-08-05
Last Updated
2026-06-12
Healthy Volunteers
Yes
Conditions
Interventions
BMS-986435
Specified dose on specified days
Locations (3)
Arizona Clinical Trials
Chandler, Arizona, United States
Panax Clinical Research
Miami Lakes, Florida, United States
Texas Liver Institute
San Antonio, Texas, United States